CNBC Stock Blog
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- 9 Stocks That Play Rising Water Costs: Strategists
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Rally Could 'Have Some Legs in 2010': Market Strategist
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
- Global Growth Good for Portfolio: Stock Picker
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Why Amazon Rules Retail
- Paul: Audit the Fed
- HP Comes in As Expected; Is It Time to Buy?
- JAL Slides to Record Low on Bankruptcy Jitters
- Prepare For Large Decline In Stocks, Next Year?
- The Social Media Gaming Threat
- Wave of Debt Payments Facing US Government
- Holiday Travel Outlook
- Gold Will Collapse Like Oil Did in 2008: Charts
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
- Obama says Boosting US Jobs is Top Priority
- More Consumers Giving 'Black Friday' the Cold Shoulder
- Prepare For Large Decline In Stocks, Next Year?
- Hewlett-Packard Earnings Rise, Match Guidance
- HP Comes in As Expected; Is It Time to Buy?
- Cramer: What Monday’s Housing Number Really Means
- Why the Dollar Will Likely Stay Weak for Some Time
- Bear, Lehman Execs Weren't Wiped Out by Crisis: Study
- How Real Estate Investors Skew Housing's Reality
RSS FEED
Text Size 
CNBC News Associate
Bob Pavlik, chief market strategist at Banyan Partners, and Charles Bobrinskoy, vice chairman and director of research at Ariel Investments, told CNBC how investors can prepare their portfolios for the week ahead. (See their stock picks, below.)
“There are a lot of stocks that continue to move up in a very positive action—but without that volume, though, there seems to be less conviction in the market,” Pavlik told CNBC.
But he counsels optimism: “The economic reports like manufacturing and personal spending all indicate that the economy is beginning to improve.”
Pavlik said his firm is heavily weighted to the stock market, with 90 percent in equities and 10 percent in cash.
In the meantime, Bobrinskoy said investors should be looking into quality stocks, as they are currently cheap.
“What’s run so far are the cyclical names, with people trying to participate in the recovery of next year,” he said. “What hasn’t run is the high quality—in particular, health care.”
In the past, Bobrinskoy had recommended Dell [DELL
Loading...
()
], Aflac [AFL
Loading...
()
] and Accenture [ACN
Loading...
()
]. But, he noted, although they’re “great quality companies,” they are not at “ridiculously cheap values” like they had once been.
Recommendations:
Pavlik Likes:
Fluor [FLR
Loading...
()
]
Bobrinskoy Likes:
Johnson & Johnson [JNJ
Loading...
()
]
IMS Health [RX
Loading...
()
]
______________________________
______________________________
Disclosures:
Pavlik does not own any shares of Flour or FMC.
Bobrinskoy’s family owns shares of Johnson & Johnson. His firm Ariel Investments owns shares of Dell, Aflac and Accenture.
______________________________
CNBC Slideshows:
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes